Filing Details
- Accession Number:
- 0001181431-13-017867
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-19 17:13:50
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-19
- Accepted Time:
- 2013-03-19 17:13:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356576 | Supernus Pharmaceuticals Inc | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1539937 | A. Jack Khattar | C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-15 | 10,000 | $6.15 | 412,058 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,125,000 | Indirect | By the KBT Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | $7.90 | 2023-02-05 | 300,000 | 300,000 | Direct | |
| Common Stock | Stock Appreciation Right | $7.90 | 2023-02-05 | 92,000 | 92,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-02-05 | 300,000 | 300,000 | Direct |
| 2023-02-05 | 92,000 | 92,000 | Direct |
Footnotes
- The option and the stock appreciation rights vest in four equal annual installments beginning on February 5, 2014.
- The reported purchase was made pursuant to a pre-arranged program for buying stock adopted on December 27, 2012, pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.20, inclusive. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
